Ford Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-276
Closed -$37 129
2021
Q4
$37 Buy
+276
New +$32.6K 0.01% 240
2021
Q3
Sell
-421
Closed -$47K 105
2021
Q2
$47K Buy
+421
New +$47.4K 0.02% 214
2018
Q1
Sell
-689
Closed -$68K 46
2017
Q4
$68K Buy
+689
New +$64.9K 0.05% 81

Other funds holding ABBV

Ford Financial Group's ABBV Position: Q1 2022 in Review

Ford Financial Group sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 276 shares — an estimated $37 sold.

Ford Financial Group first reported a position in ABBV in Q4 2017 and held it in 3 quarters. The position peaked at $68K in Q4 2017. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Ford Financial Group reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 276 AbbVie shares in Q1 2022, an estimated $37.
  • Ford Financial Group first reported a position in AbbVie in Q4 2017 and held it in 3 quarters.
  • Ford Financial Group's AbbVie position peaked at $68K in Q4 2017.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.